Non-interventional, retrospective, single arm study of individuals who have initiated a DTG/3TC regimen. Medical chart will be reviewed by the investigators. Naive subjects will be identified by the clinic database as having initiated DTG/3TC.
Study Type
OBSERVATIONAL
Enrollment
200
None(Non-interventional, retrospective chart review, single-arm study )
Chungnam National University Hospital, 282 Munwha-ro
Daejeon, South Korea
Percentage of patients achieving viral suppression
Virological suppression is HIV RNA viral load \< 50 copies/mL
Time frame: At week 48 after DTG/3TC treatment
Change in CD4+cell counts
Change in CD4+ T-cell count from baseline
Time frame: From baseline to week 48
Persistence on DTG/3TC
The percentage of patients remaining on DTG/3TC over time after initiating DTG/3TC.
Time frame: At 48 weeks
Reasons for Discontinuation
Reason for discontinuation (HBV co-infection, Virological Failure, Blip, Simplification, Drug-drug Interactions, AE/SAE, Pregnancy, Cost, Patient Preference, Follow-up loss))
Time frame: Up to 48 weeks.
Changes in BMI
Changes from baseline BMI( kg/m\^2) in treatment-Naive
Time frame: From baseline to week 48
Changes of lipid profile
Changes of lipid profile from basliene in treatment-Naive. These changes include increased levels of total cholesterol, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol, triglycerides.
Time frame: From baseline to week 48
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.